TITLE

Recurrent laryngeal papillomatosis: successful treatment with human papillomavirus vaccination

AUTHOR(S)
Mudry, Peter; Vavrina, Martin; Mazanek, Pavel; Machalova, Michaela; Litzman, Jiri; Sterba, Jaroslav
PUB. DATE
May 2011
SOURCE
Archives of Disease in Childhood -- Fetal & Neonatal Edition;May2011, Vol. 96 Issue 5, p476
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
The authors describe the case of a 5-year-old girl with recurrent laryngeal papillomatosis (RLP) due to human papillomavirus (HPV) type 11, who required frequent surgical treatment. Complete recovery occurred after HPV vaccination (Gardasil). Confirmed remission of RLP has continued during the 17 months of follow-up since vaccination. The authors conclude that HPV vaccination may represent a new therapeutic option in this situation.
ACCESSION #
60604930

 

Related Articles

  • Vaccine against HPV infection still under development. Meszaros, Liz // Dermatology Times;Aug96, Vol. 17 Issue 8, p18 

    Reports on researchers' efforts to develop an effective vaccine against human papillomaviruses (HPV). Speech on the issue by physician Lutz Gissmann at the Clinical Dermatology 2000 symposium; Classic vaccination approach to prevent infection; Therapeutic approach to treat existing infection;...

  • Young women most at risk are least likely to be offered vaccine. Wise, Jacqui // BMJ: British Medical Journal;3/22/2014, Vol. 348 Issue 7950, p3 

    The article discusses a survey on young women attending sexual health services in England and human papillomavirus (HPV) vaccine published in an issue of "Sexually Transmitted Infections." The survey found that young women most at risk of developing cervical cancer are the least likely to have...

  • The HPV Vaccine. O'Connor, Lindsey // Today's Christian Woman;Jul/Aug2007, Vol. 29 Issue 4, p30 

    The article discusses some important facts and issues to be considered in human papillomavirus vaccine.

  • THE POLITICS OF GARDASIL. O'Mara, Peggy // Mothering;May/Jun2007, Issue 142, p47 

    The article focuses on issues related to the vaccination of students with Gardasil, a new human papillomavirus (HPV) vaccine, before they can be admitted to school in various U.S. states.

  • Response. Suba, Eric J.; Raab, Stephen S. // JNCI: Journal of the National Cancer Institute;8/21/2013, Vol. 105 Issue 16, p1254 

    A letter to the editor is presented in response to the article "Population-Level Impact of the Bivalent, Quadrivalent, and Candidate Nonavalent Human Papillomavirus Vaccines: A Comparative Model-Based Analysis" by E. J. Suba and colleagues in the 2013 issue.

  • HPV: Who should receive the vaccine and why. Mahoney, Martin C. // Cortlandt Forum;Aug2007, Vol. 20 Issue 8, p31 

    The article provides a question and its answer related to the human papillomavirus (HPV) vaccine.

  • guard against gardasil. Mendenhall, Elissa // Mothering;May/Jun2007, Issue 142, p44 

    The article focuses on issues related to Gardasil, a new human papillomavirus (HPV) vaccine for preadolescent girls.

  • A Human Papillomavirus Type 16 Vaccine. Duggirala, Murali K.; Cuddihy, Maria-Teresa // New England Journal of Medicine;4/3/2003, Vol. 348 Issue 14, p1402 

    A letter to the editor is presented in response to the article "A Controlled Trial of a Human Papillomavirus Type 16 Vaccine" in the November 21, 2002 issue.

  • A Human Papillomavirus Type 16 Vaccine. Tammela, Jonathan E.; Lele, Shashikant; Odunsi, Kunle // New England Journal of Medicine;4/3/2003, Vol. 348 Issue 14, p1402 

    A letter to the editor is presented in response to the article "A Controlled Trial of a Human Papillomavirus Type 16 Vaccine" in the November 21, 2002 issue.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics